180 related articles for article (PubMed ID: 30895694)
1. The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial.
Gheflati A; Adelnia E; Nadjarzadeh A
Phytother Res; 2019 May; 33(5):1501-1509. PubMed ID: 30895694
[TBL] [Abstract][Full Text] [Related]
2. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
Darvish Damavandi R; Shidfar F; Najafi M; Janani L; Masoodi M; Akbari-Fakhrabadi M; Dehnad A
Phytother Res; 2021 Jun; 35(6):3145-3156. PubMed ID: 33880813
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease.
A Mohamed D; S Abdelgayed S; A Essa H; S Mohamed R
Pak J Biol Sci; 2018 Jan; 21(9):454-462. PubMed ID: 30724047
[TBL] [Abstract][Full Text] [Related]
4. Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D).
Dehghan F; Soori R; Gholami K; Abolmaesoomi M; Yusof A; Muniandy S; Heidarzadeh S; Farzanegi P; Ali Azarbayjani M
Sci Rep; 2016 Dec; 6():37819. PubMed ID: 27917862
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
Asghari S; Asghari-Jafarabadi M; Somi MH; Ghavami SM; Rafraf M
J Am Coll Nutr; 2018; 37(3):223-233. PubMed ID: 29313746
[TBL] [Abstract][Full Text] [Related]
6. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
[TBL] [Abstract][Full Text] [Related]
7. The effect of purslane seeds on glycemic status and lipid profiles of persons with type 2 diabetes: A randomized controlled cross-over clinical trial.
Esmaillzadeh A; Zakizadeh E; Faghihimani E; Gohari M; Jazayeri S
J Res Med Sci; 2015 Jan; 20(1):47-53. PubMed ID: 25767522
[TBL] [Abstract][Full Text] [Related]
8. Effect of purslane on blood lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.
Hadi A; Pourmasoumi M; Najafgholizadeh A; Kafeshani M; Sahebkar A
Phytother Res; 2019 Jan; 33(1):3-12. PubMed ID: 30281177
[TBL] [Abstract][Full Text] [Related]
9. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Maleki Z; Jazayeri S; Eslami O; Shidfar F; Hosseini AF; Agah S; Norouzi H
Complement Ther Med; 2019 Jun; 44():44-50. PubMed ID: 31126574
[TBL] [Abstract][Full Text] [Related]
10. Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial.
Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Haghighatdoost F; Azadbakht L
Horm Metab Res; 2017 Sep; 49(9):687-692. PubMed ID: 28759939
[TBL] [Abstract][Full Text] [Related]
11. Clinical Effects of Portulaca Oleracea Seeds on Dyslipidemia in Obese Adolescents: a Triple-blinded Randomized Controlled Trial.
Sabzghabaee AM; Kelishadi R; Jelokhanian H; Asgary S; Ghannadi A; Badri S
Med Arch; 2014 Jun; 68(3):195-9. PubMed ID: 25568533
[TBL] [Abstract][Full Text] [Related]
12. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy.
El-Sayed MI
J Ethnopharmacol; 2011 Sep; 137(1):643-51. PubMed ID: 21718775
[TBL] [Abstract][Full Text] [Related]
13. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
[TBL] [Abstract][Full Text] [Related]
14. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
[TBL] [Abstract][Full Text] [Related]
15. The effects of purslane (Portulaca oleracea) on glycemic indices: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials.
Abbasi S; Mashatan N; Farmani E; Khodashenas M; Musazadeh V; Ahrabi SS; Moridpour AH; Faghfouri AH
Phytother Res; 2023 Dec; 37(12):5529-5540. PubMed ID: 37661794
[TBL] [Abstract][Full Text] [Related]
16. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of Portulaca oleracea seeds on dyslipidemia in obese adolescents: a triple-blinded randomized controlled trial.
Sabzghabaee AM; Kelishadi R; Jelokhanian H; Asgary S; Ghannadi A; Badri S
Med Arh; 2014; 68(3):195-9. PubMed ID: 25195352
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Purslane Seeds on Biomarkers of Oxidative Stress in Diabetic Patients: A Randomized Controlled Cross-over Clinical Trial.
Zakizadeh E; Faghihimani E; Saneei P; Esmaillzadeh A
Int J Prev Med; 2015; 6():95. PubMed ID: 26605016
[TBL] [Abstract][Full Text] [Related]
19. Synergestic effect of aqueous purslane (Portulaca oleracea L.) extract and fish oil on radiation-induced damage in rats.
Abd El-Azime AS; Hussein EM; Ashry OM
Int J Radiat Biol; 2014 Dec; 90(12):1184-90. PubMed ID: 24882390
[TBL] [Abstract][Full Text] [Related]
20.
Zheng G; Mo F; Ling C; Peng H; Gu W; Li M; Chen Z
Drug Des Devel Ther; 2018; 12():47-55. PubMed ID: 29343942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
